,Keyword_1,frequency,Keyword_2,degreee
0,metabolomics,90,metabolomics,262
1,mass spectrometry,13,mass spectrometry,40
2,biomarkers,11,biomarkers,38
3,metabolome,9,metabolome,32
4,nmr,6,nmr,25
5,lc-ms,6,lc-ms,20
6,metabolite profiling,6,metabolite profiling,19
7,metabolic profiling,6,metabolic profiling,19
8,biomarker,5,biomarker,14
9,association,4,gc-ms,13
10,nuclear magnetic resonance,4,metabolites,12
11,liquid,4,data,11
12,mass,3,lipidomics,11
13,data,3,nuclear magnetic resonance,11
14,data processing,3,data processing,10
15,gc-ms,3,metabolic,10
16,lipidomics,3,genomics,10
17,biomarker discovery,3,ce-ms,10
18,metabolic,3,liquid,10
19,metabolism,3,mass,9
20,genomics,3,metabolism,9
21,nsclc,3,systems biology,9
22,metabolites,3,nsclc,8
23,multivariate analysis,3,drug discovery,8
24,systems biology,3,drug,8
25,pharmacometabolomics,2,annotation,8
26,lc-ms/ms,2,pca,8
27,metabolite,2,chromatography,8
28,toxicity,2,pharmacometabolomics,7
29,disease,2,metabolite,7
30,liquid chromatography,2,omics,7
31,microbiomics,2,biomarker discovery,7
32,omics,2,stem cells,7
33,hepatocellular carcinoma,2,multivariate analysis,7
34,stem cells,2,exposome,7
35,cardiovascular diseases,2,databases,7
36,egfr mutation,2,drug efficacy,7
37,drug discovery,2,functional genomics,7
38,drug,2,minimum,7
39,ce-ms,2,lc-ms/ms,6
40,exposome,2,toxicity,6
41,annotation,2,liquid chromatography,6
42,databases,2,microbiomics,6
43,data analysis,2,hepatocellular carcinoma,6
44,cancer,2,study design,6
45,pca,2,sample extraction,6
46,chromatography,2,data analysis,6
47,traditional chinese medicine,2,cancer,6
48,oncology,2,metabonomics,6
49,drug efficacy,2,association,5
50,functional genomics,2,disease,5
51,metabonomics,2,network,5
52,minimum,2,software,5
53,epidemiology,1,statistics,5
54,early-career scientists,1,visualization,5
55,challenges,1,workflow,5
56,als,1,cardiovascular diseases,5
57,therapeutic,1,egfr mutation,5
58,creatinine,1,preclinical,5
59,eye disease,1,clinical,5
60,traditional chinese medicines,1,gc/ms,5
61,cirrhosis,1,psoriasis,5
62,liver,1,psoriatic arthritis,5
63,mortality,1,skin,5
64,crop plant breeding,1,urine,5
65,metabolic traits,1,comprehensive coverage,5
66,nuclear,1,data quality,5
67,quantitative trait loci,1,ms,5
68,nitrogen-metabolism,1,plama,5
69,ambient mass spectrometry,1,reliability,5
70,lc-ms-based metabolomics,1,sample,5
71,medicine,1,als,4
72,autism spectrum disorder,1,therapeutic,4
73,autism,1,creatinine,4
74,rheumatic,1,eye disease,4
75,"nuclear magnetic resonance, biomolecular",1,aquaculture,4
76,melanoma,1,marine,4
77,network,1,alzheimer's disease,4
78,software,1,animal models,4
79,statistics,1,scale-free networks,4
80,visualization,1,complex systems,4
81,workflow,1,pathways,4
82,asthma,1,modelling,4
83,respiratory tract infections,1,pharmaceutical,4
84,systems approach,1,smartphone,4
85,pathway,1,schisandra sinensis,4
86,network analysis,1,uv-vis,4
87,correlation network,1,nutritional metabolomics,4
88,association network,1,cat,4
89,aquaculture,1,dog,4
90,marine,1,animals,4
91,alzheimer's disease,1,cancer diagnosis,4
92,animal models,1,diagnostic biomarkers,4
93,quality control,1,integrated approach,4
94,unwanted variation,1,plant metabolomics,4
95,bias,1,diagnostic biomarker,4
96,standard operating procedures,1,transgenic,4
97,remote ischemic preconditioning,1,food,4
98,drosophila,1,genetically modified organism,4
99,state of the art,1,crops,4
100,scale-free networks,1,food composition,4
101,complex systems,1,foodomics,4
102,pathways,1,food quality,4
103,modelling,1,food safety,4
104,diagnosis and therapy,1,traditional chinese medicine,4
105,stroke,1,oncology,4
106,free radicals/free-radical scavengers,1,drug discovery and development,4
107,heart failure metabolomics,1,environment,4
108,arginine,1,human health,4
109,nitric oxide,1,life-course epidemiology,4
110,myocardial energy,1,biomaterials,4
111,gdm,1,regenerative,4
112,newborn,1,global,4
113,liquid chromatography-mass spectrometry,1,untargeted,4
114,peak alignment,1,metaolomics,4
115,breast milk,1,metabolic fingerprinting,4
116,in-stent restenosis,1,pls,4
117,cdx,1,chemical diversity,4
118,artificial intelligence,1,ecology,4
119,bayesian inference networks,1,evolution,4
120,aha scientific statements,1,herbivore,4
121,precision medicine,1,ions,4
122,high resolution metabolomics,1,ion suppression,4
123,prognostic prediction,1,targeted metabolomics,4
124,chemotherapy,1,genetics,4
125,preclinical,1,personalized medicine,4
126,clinical,1,standard,4
127,gc/ms,1,environmental,4
128,system biology,1,reporting requirements,4
129,high-throughput screening,1,controlled vocabulary,4
130,psoriasis,1,terminology,4
131,psoriatic arthritis,1,semantic,4
132,skin,1,metadata,4
133,urine,1,epidemiology,3
134,medium chain fatty acids,1,early-career scientists,3
135,traumatic brain injury,1,challenges,3
136,small molecules,1,traditional chinese medicines,3
137,spectroscopy,1,cirrhosis,3
138,principal component analysis,1,liver,3
139,myocardial,1,mortality,3
140,pharmaceutical,1,crop plant breeding,3
141,personalized,1,metabolic traits,3
142,chemical derivatization,1,nuclear,3
143,in-house endogenous databases,1,ambient mass spectrometry,3
144,id-based metabolomics analysis,1,lc-ms-based metabolomics,3
145,data pre-processing,1,medicine,3
146,univariate analysis,1,autism spectrum disorder,3
147,male infertility,1,autism,3
148,metabolomics technologies,1,asthma,3
149,study design,1,respiratory tract infections,3
150,sample extraction,1,systems approach,3
151,penetrating ballistic-like brain injury,1,pathway,3
152,smartphone,1,network analysis,3
153,schisandra sinensis,1,correlation network,3
154,uv-vis,1,association network,3
155,comprehensive coverage,1,quality control,3
156,data quality,1,unwanted variation,3
157,ms,1,bias,3
158,plama,1,standard operating procedures,3
159,reliability,1,drosophila,3
160,sample,1,state of the art,3
161,cancer metabolomics,1,diagnosis and therapy,3
162,human metabolome database (hmdb),1,stroke,3
163,amyotrophic lateral sclerosis,1,free radicals/free-radical scavengers,3
164,diagnosis,1,heart failure metabolomics,3
165,data acquisition and analysis,1,arginine,3
166,informatics techniques,1,nitric oxide,3
167,preterm birth,1,myocardial energy,3
168,nursing,1,breast milk,3
169,complex mixture analysis,1,cdx,3
170,metabolite databases,1,artificial intelligence,3
171,ms of,1,bayesian inference networks,3
172,network-based,1,precision medicine,3
173,database design,1,high resolution metabolomics,3
174,targeted and untargeted metabolomics,1,prognostic prediction,3
175,dissolved organic matter,1,chemotherapy,3
176,bioindicators,1,system biology,3
177,environmental metabolomics,1,high-throughput screening,3
178,metabolomic,1,small molecules,3
179,principal components,1,spectroscopy,3
180,individualized medicine,1,principal component analysis,3
181,energy,1,myocardial,3
182,nutritional metabolomics,1,male infertility,3
183,cat,1,metabolomics technologies,3
184,dog,1,amyotrophic lateral sclerosis,3
185,animals,1,diagnosis,3
186,toxicometabolomics,1,preterm birth,3
187,quality assurance,1,nursing,3
188,human toxome,1,complex mixture analysis,3
189,cancer diagnosis,1,metabolite databases,3
190,diagnostic biomarkers,1,ms of,3
191,anti-infective,1,bioindicators,3
192,antimicrobial,1,environmental metabolomics,3
193,drug mechanism,1,metabolomic,3
194,infectious diseases,1,principal components,3
195,statistical methods,1,individualized medicine,3
196,gas chromatography-mass spectrometry,1,energy,3
197,extreme environments,1,toxicometabolomics,3
198,mitochondria,1,quality assurance,3
199,extracellular vesicles,1,human toxome,3
200,exosomes,1,anti-infective,3
201,microvesicles,1,antimicrobial,3
202,integrated approach,1,drug mechanism,3
203,plant metabolomics,1,infectious diseases,3
204,diagnostic biomarker,1,statistical methods,3
205,lychnophorinae,1,extracellular vesicles,3
206,transgenic,1,exosomes,3
207,food,1,microvesicles,3
208,genetically modified organism,1,lychnophorinae,3
209,crops,1,mammalian cells,3
210,chinese medicine theory,1,sample processing,3
211,chinese medicine syndrome,1,protists,3
212,food composition,1,gas and liquid,3
213,foodomics,1,metabolic pathways,3
214,food quality,1,metabotype,3
215,food safety,1,personalised health,3
216,pathways of toxicity,1,kidney disease,3
217,toxicity testing for the 21st,1,therapeutic target,3
218,mammalian cells,1,toxicology,3
219,sample processing,1,preclinical research,3
220,processing technology,1,regulatory toxicology,3
221,pediatrics,1,isa-tab,3
222,drug discovery and development,1,isa commons,3
223,protists,1,chemicals,3
224,gas and liquid,1,characterisation,3
225,metabolomics society,1,multivariate data analysis,3
226,global initiatives,1,chemometrics,3
227,national programmes,1,adverse drug reactions,3
228,metabolic pathways,1,drug discovery and,3
229,metabotype,1,analytical methods,3
230,personalised health,1,gas chromatography,3
231,kidney disease,1,in vivo sampling,3
232,therapeutic target,1,colorectal cancer,3
233,toxicology,1,diagnostic test,3
234,preclinical research,1,metabolomics screening,3
235,regulatory toxicology,1,serum tissue,3
236,isa-tab,1,atherosclerosis,3
237,isa commons,1,coronary artery disease,3
238,environment,1,biological samples,3
239,human health,1,data treatment,3
240,life-course epidemiology,1,standardization,3
241,biomaterials,1,metabolite identification,3
242,regenerative,1,environmental microorganism,3
243,future of medicine,1,biodegradation,3
244,information and communication,1,pattern recognition,3
245,biomarker identification,1,quantitative trait loci,2
246,biology,1,nitrogen-metabolism,2
247,global,1,rheumatic,2
248,untargeted,1,"nuclear magnetic resonance, biomolecular",2
249,kernel methods,1,melanoma,2
250,fisher discriminant analysis (fda),1,remote ischemic preconditioning,2
251,chemicals,1,gdm,2
252,characterisation,1,newborn,2
253,multivariate data analysis,1,liquid chromatography-mass spectrometry,2
254,chemometrics,1,peak alignment,2
255,metabolic flux analysis,1,in-stent restenosis,2
256,mass isotopomer distribution,1,aha scientific statements,2
257,adverse drug reactions,1,medium chain fatty acids,2
258,drug discovery and,1,traumatic brain injury,2
259,screening and diagnosis,1,chemical derivatization,2
260,personalized cancer care,1,in-house endogenous databases,2
261,tumorigenesis,1,id-based metabolomics analysis,2
262,analytical methods,1,data pre-processing,2
263,gas chromatography,1,univariate analysis,2
264,in vivo sampling,1,cancer metabolomics,2
265,bacterial and plant applications,1,human metabolome database (hmdb),2
266,biomedical and clinical applications,1,data acquisition and analysis,2
267,metaolomics,1,informatics techniques,2
268,metabolic fingerprinting,1,database design,2
269,pls,1,targeted and untargeted metabolomics,2
270,colorectal cancer,1,dissolved organic matter,2
271,diagnostic test,1,gas chromatography-mass spectrometry,2
272,metabolomics screening,1,extreme environments,2
273,serum tissue,1,mitochondria,2
274,atherosclerosis,1,chinese medicine theory,2
275,coronary artery disease,1,chinese medicine syndrome,2
276,chemical diversity,1,pathways of toxicity,2
277,ecology,1,toxicity testing for the 21st,2
278,evolution,1,processing technology,2
279,herbivore,1,pediatrics,2
280,ions,1,metabolomics society,2
281,ion suppression,1,global initiatives,2
282,targeted metabolomics,1,national programmes,2
283,biological samples,1,future of medicine,2
284,data treatment,1,information and communication,2
285,genetics,1,biomarker identification,2
286,personalized medicine,1,biology,2
287,quantitative systems biology,1,kernel methods,2
288,"high-throughput ""omic"" techniques",1,fisher discriminant analysis (fda),2
289,standardization,1,metabolic flux analysis,2
290,standard,1,mass isotopomer distribution,2
291,environmental,1,screening and diagnosis,2
292,reporting requirements,1,personalized cancer care,2
293,metabolite identification,1,tumorigenesis,2
294,data exchange,1,quantitative systems biology,2
295,data format,1,"high-throughput ""omic"" techniques",2
296,metabolomics standards initiative,1,data exchange,2
297,controlled vocabulary,1,data format,2
298,terminology,1,metabolomics standards initiative,2
299,semantic,1,personalized,1
300,metadata,1,penetrating ballistic-like brain injury,1
301,environmental microorganism,1,network-based,1
302,biodegradation,1,bacterial and plant applications,1
303,pattern recognition,1,biomedical and clinical applications,1
